ALDH1A1 and osteoporosis: These studies collectively suggest that the ALDH1 family represents a crucial potential therapeutic target for osteoarticular diseases and may lead to the development of novel targeted treatment strategies addressing mechanical inflammation in patients with OA and osteoporosis (Zhu et al., 2022).